High rate of abnormal blood values and vascular complications before diagnosis of myeloproliferative neoplasmsAnneli Enblom‐Larsson, Björn Andréasson, Emma Lindskog et al.|European Journal of Internal Medicine|2015Cited by 59
A retrospective analysis of the impact of treatments and blood counts on survival and the risk of vascular events during the course of polycythaemia veraAnneli Enblom‐Larsson, Björn Andréasson, François Girodon et al.|British Journal of Haematology|2017Cited by 14
Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera—A matched nationwide population‐based studyAnneli Enblom‐Larsson, Anders Själander, Maria Liljeholm et al.|British Journal of Haematology|2024Cited by 11
Thrombosis, major bleeding, and mortality in 1079 patients with myelofibrosis: a matched population-based studyAnneli Enblom‐Larsson, Anders Själander, Henrik Renlund et al.|Blood Advances|2025Cited by 8
Survival and risk of vascular complications in myelofibrosis—A <scp>population‐based</scp> study from the Swedish <scp>MPN</scp> groupMarie Lindgren, Erik Ahlstrand, Björn Andréasson et al.|European Journal Of Haematology|2022Cited by 5